52.14
price up icon4.16%   2.08
after-market アフターアワーズ: 52.55 0.41 +0.79%
loading

Corcept Therapeutics Inc (CORT) 最新ニュース

pulisher
12:45 PM

Here is Why Growth Investors Should Buy Corcept (CORT) Now - Yahoo Finance

12:45 PM
pulisher
12:00 PM

Corcept (CORT) Upgraded to Strong Buy: Here's Why - Yahoo Finance

12:00 PM
pulisher
09:15 AM

Corcept Therapeutics Incorporated (CORT) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance Australia

09:15 AM
pulisher
09:04 AM

Corcept Stock At New High; Will The Upcoming Regulatory And Clinical Trial Catalysts Take It Higher? - RTTNews

09:04 AM
pulisher
05:42 AM

Roman Butler Fullerton & Co. Sells 10,466 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

05:42 AM
pulisher
03:11 AM

Creative Planning Acquires 841 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

03:11 AM
pulisher
Nov 04, 2024

Corcept Therapeutics (NASDAQ:CORT) Reaches New 1-Year HighStill a Buy? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics stock soars to all-time high of $50.23 By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics stock soars to all-time high of $50.23 - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Wall Street Analysts Believe Corcept (CORT) Could Rally 56.66%: Here's is How to Trade - Yahoo Canada Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Recent Price Trend in Corcept (CORT) is Your Friend, Here's Why - Yahoo Canada Finance

Nov 04, 2024
pulisher
Nov 04, 2024

What is HC Wainwright’s Forecast for CORT FY2024 Earnings? - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Research Analysts Issue Forecasts for CORT FY2024 Earnings - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

What is HC Wainwright’s Estimate for CORT FY2026 Earnings? - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Corcept Therapeutics (CORT) Stock Declines Amid Market Activity - GuruFocus.com

Nov 02, 2024
pulisher
Nov 01, 2024

Earnings Estimates Moving Higher for Corcept (CORT): Time to Buy? - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 3.2%Here's What Happened - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

FY2026 Earnings Estimate for CORT Issued By HC Wainwright - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept’s relacorilant GRADIENT trial misses primary endpoint - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Earnings call: Corcept Therapeutics reports robust Q3 growth, raises guidance - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept Therapeutics Inc (CORT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept Therapeutics Inc (CORT) Q3 2024 Earnings: EPS of $0.41 B - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

HC Wainwright Reiterates Buy Rating for Corcept Therapeutics (NASDAQ:CORT) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept Therapeutics (CORT) Tops Q3 Earnings and Revenue Estimates - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept: Q3 Earnings Snapshot - Milford Mirror

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept reports robust revenue growth in Q3 By Investing.com - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

abrdn plc Purchases 142,310 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Corcept Therapeutics Announces Third Quarter Financial Results, Positive Results From Phase 3 GRADIENT Trial in Patients With Cushing’s Syndrome and Provides Corporate Update - StockTitan

Oct 30, 2024
pulisher
Oct 29, 2024

Earnings Preview: Corcept Therapeutics - Benzinga

Oct 29, 2024
pulisher
Oct 26, 2024

Boston Trust Walden Corp Sells 69,924 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Oct 26, 2024
pulisher
Oct 24, 2024

Corcept Therapeutics (CORT) Set to Announce Earnings on Wednesday - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

Zacks.com featured highlights Idaho Strategic, Qifu, Sezzle, Corcept and FinWise - Yahoo Finance

Oct 23, 2024
pulisher
Oct 21, 2024

Corcept stock stays a buy, with analyst eyeing validation of relacorilant’s cancer-fighting mechanism - Investing.com UK

Oct 21, 2024
pulisher
Oct 21, 2024

Analysts Set Corcept Therapeutics Incorporated (NASDAQ:CORT) PT at $65.25 - Defense World

Oct 21, 2024
pulisher
Oct 19, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Position Reduced by Exchange Traded Concepts LLC - Defense World

Oct 19, 2024
pulisher
Oct 19, 2024

Exchange Traded Concepts LLC Decreases Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Oct 19, 2024
pulisher
Oct 18, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Corcept Therapeutics (CORT) Stock Jumps Over 5% Amid Solid Finan - GuruFocus.com

Oct 18, 2024
pulisher
Oct 18, 2024

HC Wainwright Increases Corcept Therapeutics (NASDAQ:CORT) Price Target to $80.00 - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Corcept Therapeutics stock target raised, buy rating on Cushing's franchise growth - Investing.com Canada

Oct 18, 2024
pulisher
Oct 18, 2024

Key Takeaways From Corcept Therapeutics Analyst Ratings - Benzinga

Oct 18, 2024
pulisher
Oct 17, 2024

Corcept Therapeutics (NASDAQ:CORT) Sets New 12-Month HighHere's Why - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Corcept Therapeutics stock hits all-time high at $47.81 - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Corcept Therapeutics stock hits all-time high at $47.81 By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 17, 2024

Corcept (CORT) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Cetera Investment Advisers Boosts Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Oct 17, 2024
pulisher
Oct 17, 2024

Creative Planning Purchases 1,794 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

Here's Why Investors Should Consider Buying Corcept Stock Now - MSN

Oct 16, 2024
pulisher
Oct 15, 2024

Truist upgrades Corcept Therapeutics Inc (CORT) rating to a Buy - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Corcept Therapeutics Inc (CORT) stock analysis: A simple moving average approach - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Financial Analysis: Corcept Therapeutics Inc (CORT)’s Ratios Unveil Key Insights - The Dwinnex

Oct 15, 2024
pulisher
Oct 15, 2024

Implied Volatility Surging for Corcept Therapeutics (CORT) Stock Options - Yahoo Finance

Oct 15, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):